Pharyngitis medical therapy: Difference between revisions
Sergekorjian (talk | contribs) |
|||
(50 intermediate revisions by 9 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pharyngitis}} | {{Pharyngitis}} | ||
{{CMG}};{{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}}, {{VSKP}} | ||
==Overview== | ==Overview== | ||
The majority of cases of pharyngitis are self-limited and only require symptomatic therapy. | The majority of cases of [[pharyngitis]] are [[self-limited]] and only require [[symptomatic therapy]]. Accurate diagnosis of [[streptococcal]] [[pharyngitis]] followed by appropriate [[antimicrobial]] therapy is important for the prevention of [[acute rheumatic fever]], for the prevention of [[suppurative]] complications (e.g, [[peritonsillar abscess]], [[cervical]] [[lymphadenitis]], [[mastoiditis]], and, possibly, other invasive infections), to improve clinical symptoms and signs, for the rapid decrease in [[contagiousness]], for the reduction in transmission of [[Group A streptococcal|GAS]] to family members, classmates, and other close contacts of the patient to allow for the rapid resumption of usual activities; and for the minimization of potential adverse effects of inappropriate [[antimicrobial]] therapy. | ||
==Medical Therapy== | ==Medical Therapy== | ||
*Acute pharyngitis should be treated according to the etiologic agent | *[[Acute pharyngitis]] should be treated according to the etiologic agent.<ref name="pmid23091044">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. (2012) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23091044 Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.] ''Clin Infect Dis'' 55 (10):1279-82. [http://dx.doi.org/10.1093/cid/cis847 DOI:10.1093/cid/cis847] PMID: [https://pubmed.gov/23091044 23091044]</ref> | ||
*As [[viral]] infections are the most common causes of [[pharyngitis]] in children, most patients do not require treatment and only need [[supportive care]].<ref name="pmid8637780">Bisno AL (1996) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8637780 Acute pharyngitis: etiology and diagnosis.] ''Pediatrics'' 97 (6 Pt 2):949-54. PMID: [https://pubmed.gov/8637780 8637780]</ref> | |||
* | * [[Bacterial]] [[pharyngitis]] is common among young children and adolescents. [[Group A streptococcal pharyngitis]] is the only common form of the disease for which [[antimicrobial]] therapy is definitely indicated. Therefore, when a clinician evaluates a patient with an acute sore throat, the most important clinical task is to decide whether or not the patient has “strep throat.”<ref name="pmid11172144">Bisno AL (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11172144 Acute pharyngitis.] ''N Engl J Med'' 344 (3):205-11. [http://dx.doi.org/10.1056/NEJM200101183440308 DOI:10.1056/NEJM200101183440308] PMID: [https://pubmed.gov/11172144 11172144]</ref> | ||
=== | ===Corticosteroids=== | ||
[[Corticosteroids]] have been studied and recommended by a guideline<ref name="pmid28931507">{{cite journal| author=Aertgeerts B, Agoritsas T, Siemieniuk RAC, Burgers J, Bekkering GE, Merglen A et al.| title=Corticosteroids for sore throat: a clinical practice guideline. | journal=BMJ | year= 2017 | volume= 358 | issue= | pages= j4090 | pmid=28931507 | doi=10.1136/bmj.j4090 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28931507 }} [http://annals.org/aim/fullarticle/2669671/guideline-experts-recommend-single-dose-oral-steroids-pain-relief-acute ACPJC review]</ref>, but results were heterogeneous in a [[meta-analysis]]<ref name="pmid28931508">{{cite journal| author=Sadeghirad B, Siemieniuk RAC, Brignardello-Petersen R, Papola D, Lytvyn L, Vandvik PO et al.| title=Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. | journal=BMJ | year= 2017 | volume= 358 | issue= | pages= j3887 | pmid=28931508 | doi=10.1136/bmj.j3887 | pmc=5605780 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28931508 }} </ref>. | |||
The most recent trial in the meta-analysis showed<ref name="pmid28418482">{{cite journal| author=Hayward GN, Hay AD, Moore MV, Jawad S, Williams N, Voysey M | display-authors=etal| title=Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial. | journal=JAMA | year= 2017 | volume= 317 | issue= 15 | pages= 1535-1543 | pmid=28418482 | doi=10.1001/jama.2017.3417 | pmc=5470351 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28418482 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=28806797 Review in: Ann Intern Med. 2017 Aug 15;167(4):JC16] </ref>: | |||
* Insignificant benefit in the primary outcome at 24 hours. [[Risk difference]] of 4.7% (95% CI, −1.8% to 11.2%) | |||
* Significant benefit at the secondary outcome of 48 hours. [[Risk difference]] of 8.7% (95% CI, 1.2% to 16.2%) | |||
=== | ===Other Treatment Regimen=== | ||
* | {| class="wikitable" | ||
|- | |||
! style="width: 34%;" | '''Supportive Therapies''' | |||
! style="width: 33%;" | '''Systemic Therapy''' | |||
! style="width: 33%;" | '''Antimicrobial Regimens''' | |||
|- | |||
| valign="top" | | |||
'''Topical therapy''' | |||
* Oral rinses were more effective in treating conditions affecting oral cavity and base of the tongue whereas sprays were more effective in coating the [[posterior pharynx]] and hence they were used to treat posterior pharynx conditions.<ref name="pmid10767923">Patel SK, Ghufoor K, Jayaraj SM, McPartlin DW, Philpott J (1999) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10767923 Pictorial assessment of the delivery of oropharyngeal rinse versus oropharyngeal spray.] ''J Laryngol Otol'' 113 (12):1092-4. PMID: [https://pubmed.gov/10767923 10767923]</ref> | |||
'''Oral rinses''' | |||
*Saltwater gargles do not demonstrate any benefit in relieving throat pain. There are minimal side effects associated with these oral rinses. | |||
*[[Lidocaine]], [[Diphenhydramine]] and [[Maalox]] ([[Aluminium hydroxide]], [[magnesium hydroxide]] and simethicone) have shown to be helpful. This combination can be used to treat Coxsackie A or B infection or herpes simplex. Avoid using the lidocaine over its recommended use.<ref name="pmid3382075">Hess GP, Walson PD (1988) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=3382075 Seizures secondary to oral viscous lidocaine.] ''Ann Emerg Med'' 17 (7):725-7. PMID: [https://pubmed.gov/3382075 3382075]</ref><ref name="pmid7899121">Gonzalez del Rey J, Wason S, Druckenbrod RW (1994) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=7899121 Lidocaine overdose: another preventable case?] ''Pediatr Emerg Care'' 10 (6):344-6. PMID: [https://pubmed.gov/7899121 7899121]</ref> | |||
*[[Benzydamine]] hydrochloride rinses have shown to help reduce the pain in a few cases. However, they are used more frequently to treat radiation mucositis.<ref name="pmid7600413">Turnbull RS (1995) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=7600413 Benzydamine Hydrochloride (Tantum) in the management of oral inflammatory conditions.] ''J Can Dent Assoc'' 61 (2):127-34. PMID: [https://pubmed.gov/7600413 7600413]</ref><ref name="pmid11589263">Passàli D, Volonté M, Passàli GC, Damiani V, Bellussi L, MISTRAL Italian Study Group (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11589263 Efficacy and safety of ketoprofen lysine salt mouthwash versus benzydamine hydrochloride mouthwash in acute pharyngeal inflammation: a randomized, single-blind study.] ''Clin Ther'' 23 (9):1508-18. PMID: [https://pubmed.gov/11589263 11589263]</ref> | |||
'''Sprays''' | |||
*Topical [[anesthetic]] sprays have been used in the past to treat pharyngitis, however, their effect is not significant. They may also cause a few [[allergic]] reactions and side effects, such as [[methemoglobinemia]], and should not be used in children. | |||
*[[Chlorhexidine]] / [[benzydamine]] sprays are more effective in alleviating symptoms of acute [[viral pharyngitis]] and group A streptococcal pharyngitis.<ref name="pmid21310101">Cingi C, Songu M, Ural A, Erdogmus N, Yildirim M, Cakli H et al. (2011) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=21310101 Effect of chlorhexidine gluconate and benzydamine hydrochloride mouth spray on clinical signs and quality of life of patients with streptococcal tonsillopharyngitis: a multicentre, prospective, randomized, double-blinded, placebo-controlled study.] ''J Laryngol Otol'' 125 (6):620-5. [http://dx.doi.org/10.1017/S0022215111000065 DOI:10.1017/S0022215111000065] PMID: [https://pubmed.gov/21310101 21310101]</ref><ref name="pmid21086279">Cingi C, Songu M, Ural A, Yildirim M, Erdogmus N, Bal C (2010) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=21086279 Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: a prospective, randomized, double-blind, placebo-controlled, multicenter study.] ''Ear Nose Throat J'' 89 (11):546-9. PMID: [https://pubmed.gov/21086279 21086279]</ref> | |||
'''Lozenges''' | |||
*Medical throat [[lozenges]] help reducing the duration of symptoms and also provide with some symptomatic relief. They are not recommended for children, as there is a risk of choking. [[Lozenges]] containing [[antiseptics]], [[menthol]], [[anesthetics]], and [[anti-inflammatory]] agents have been used.<ref name="pmid11172144">Bisno AL (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11172144 Acute pharyngitis.] ''N Engl J Med'' 344 (3):205-11. [http://dx.doi.org/10.1056/NEJM200101183440308 DOI:10.1056/NEJM200101183440308] PMID: [https://pubmed.gov/11172144 11172144]</ref>. Flurbiprofen (trade name Strefen) lozenges may help<ref name="pmid11198725">Watson N, Nimmo WS, Christian J, Charlesworth A, Speight J, Miller K (2000) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11198725 Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety.] ''Int J Clin Pract'' 54 (8):490-6. PMID: [https://pubmed.gov/11198725 11198725]</ref>. [[Amylmetacresol]] and [[2,4-Dichlorobenzylalcohol]] (AMC/DCBA) lozenges (trade names [[Strepsils]], [[Lorsept]], and [[Gorpils]]) may help<ref name="pmid28869700">{{cite journal| author=Weckmann G, Hauptmann-Voß A, Baumeister SE, Klötzer C, Chenot JF| title=Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis. | journal=Int J Clin Pract | year= 2017 | volume= | issue= | pages= | pmid=28869700 | doi=10.1111/ijcp.13002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28869700 }} </ref>. | |||
| valign="top" | | |||
'''Analgesics''' | |||
* [[Analgesics]] are prescribed for moderate to severe pain. [[Acetaminophen]], [[Nonsteroidal anti-inflammatory]] drugs ([[NSAID]]s) have shown to decrease pain symptoms. They may also help in reducing [[fever]] and [[inflammation]].<ref name="pmid11127175">Thomas M, Del Mar C, Glasziou P (2000) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11127175 How effective are treatments other than antibiotics for acute sore throat?] ''Br J Gen Pract'' 50 (459):817-20. PMID: [https://pubmed.gov/11127175 11127175]</ref><ref name="pmid17535039">Gehanno P, Dreiser RL, Ionescu E, Gold M, Liu JM (2003) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=17535039 Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat.] ''Clin Drug Investig'' 23 (4):263-71. PMID: [https://pubmed.gov/17535039 17535039]</ref> [[Aspirin]] should be avoided in children as it may cause [[Reye's syndrome]]. For severe pain, [[codeine]] may be added to the [[NSAID]]. | |||
'''Glucocorticoids''' | |||
* [[Glucocorticoid]]s may alleviate pain, and may also be beneficial in patients of [[Group A streptococcal pharyngitis]]. No benefits were obtained by adding single-dose [[glucocorticoid]] to [[antimicrobial]] therapy in children.<ref name="pmid15753273">Olympia RP, Khine H, Avner JR (2005) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15753273 Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children.] ''Arch Pediatr Adolesc Med'' 159 (3):278-82. [http://dx.doi.org/10.1001/archpedi.159.3.278 DOI:10.1001/archpedi.159.3.278] PMID: [https://pubmed.gov/15753273 15753273]</ref><ref name="pmid8427434">O'Brien JF, Meade JL, Falk JL (1993) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8427434 Dexamethasone as adjuvant therapy for severe acute pharyngitis.] ''Ann Emerg Med'' 22 (2):212-5. PMID: [https://pubmed.gov/8427434 8427434]</ref><ref name="pmid12712025">Bulloch B, Kabani A, Tenenbein M (2003) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=12712025 Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial.] ''Ann Emerg Med'' 41 (5):601-8. [http://dx.doi.org/10.1067/mem.2003.136 DOI:10.1067/mem.2003.136] PMID: [https://pubmed.gov/12712025 12712025]</ref> Because there are safer and more effective alternatives than [[glucocorticoids]] for pain relief associated with fewer side effects, they not recommended for symptomatic relief of throat pain. | |||
| valign="top" | | |||
'''Streptococcal pharyngitis'''<ref name="pmid11172144">Bisno AL (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11172144 Acute pharyngitis.] ''N Engl J Med'' 344 (3):205-11. [http://dx.doi.org/10.1056/NEJM200101183440308 DOI:10.1056/NEJM200101183440308] PMID: [https://pubmed.gov/11172144 11172144]</ref> | |||
*Preferred regimen (children): [[Penicillin V]] 250 mg PO bid-tid for 10 days | |||
== | *Preferred regimen (adolescents and adults): [[Penicillin V]] 250 mg PO qid {{or}} 500 mg PO bid for 10 days | ||
*Alternative regimen (1): [[Amoxicillin]] 50 mg/kg PO qd for 10 days (maximum dose 1 g/day) {{or}} 25 mg/kg bid for 10 days (maximum dose 500 mg/day) | |||
*Alternative regimen (2): [[Penicillin G|Benzathine Penicillin G]] 0.6 MU (<27 kg)/ 1.2 MU (≥27 kg) IM single dose | |||
*Alternative regimen (3): [[Cephalexin]] 20 mg/kg PO bid for 10 days (maximum 500 mg/dose) | |||
*Alternative regimen (4): [[Cefadroxil]] 30 mg/kg PO qd for 10 days (maximum dose 1 g/day) | |||
*Alternative regimen (5): [[Clindamycin]] 7 mg/kg PO tid for 10 days (maximum 300 mg/dose) | |||
: | *Alternative regimen (6): [[Clarithromycin]] 7.5 mg/kg PO bid for 10 days (maximum 250 mg/dose) | ||
'''Other bacterial pharyngitis''' | |||
*'''[[Arcanobacterium haemolyticum]]''': [[Erythromycin]] is the preferred drug.<ref name="pmid11172144">Bisno AL (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11172144 Acute pharyngitis.] ''N Engl J Med'' 344 (3):205-11. [http://dx.doi.org/10.1056/NEJM200101183440308 DOI:10.1056/NEJM200101183440308] PMID: [https://pubmed.gov/11172144 11172144]</ref> | |||
*[[Neisseria gonorrhoeae]]: If uncomplicated<ref name="pmid11172144">Bisno AL (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11172144 Acute pharyngitis.] ''N Engl J Med'' 344 (3):205-11. [http://dx.doi.org/10.1056/NEJM200101183440308 DOI:10.1056/NEJM200101183440308] PMID: [https://pubmed.gov/11172144 11172144]</ref> | |||
**single dose of intramuscular [[ceftriaxone]] (125 mg) or a single dose of an oral [[quinolone]] ([[ciprofloxacin]], 500 mg, or [[ofloxacin]], 400 mg) + | |||
**single dose of [[azithromycin]] (1 g) or [[doxycycline]] (100 mg) twice daily for seven days for possible [[chlamydial]] [coinfection]] at genital sites. | |||
**[[Doxycycline]] and [[ofloxacin]] should not be prescribed for pregnant women. | |||
|} | |||
:::* | |||
==Chronic Carriers of Group A Streptococci== | ==Chronic Carriers of Group A Streptococci== | ||
Antimicrobial therapy is not indicated for majority of chronic carriers. A few conditions where antibiotics are recommended are: | Antimicrobial therapy is not indicated for the majority of chronic carriers. A few conditions where antibiotics are recommended are: | ||
#An outbreak of [[rheumatic fever]], acute [[poststreptococcal glomerulonephritis]] or invasive GAS infection | #An outbreak of [[rheumatic fever]], acute [[poststreptococcal glomerulonephritis]] or invasive GAS infection | ||
#Closed community outbreak of GAS pharyngitis | #Closed community outbreak of GAS pharyngitis | ||
#Family history | #Family history of [[acute rheumatic fever]] | ||
#Excessive anxiety about rheumatic fever | #Excessive anxiety about [[rheumatic fever]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency | [[Category:Emergency mdicine]] | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Otolaryngology]] | [[Category:Otolaryngology]] | ||
[[Category: | [[Category:Pediatrics]] | ||
[[Category: | [[Category:Immunology]] | ||
[[Category:Gastroenterology]] |
Latest revision as of 22:48, 11 December 2020
Pharyngitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pharyngitis medical therapy On the Web |
American Roentgen Ray Society Images of Pharyngitis medical therapy |
Risk calculators and risk factors for Pharyngitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2], Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [3]
Overview
The majority of cases of pharyngitis are self-limited and only require symptomatic therapy. Accurate diagnosis of streptococcal pharyngitis followed by appropriate antimicrobial therapy is important for the prevention of acute rheumatic fever, for the prevention of suppurative complications (e.g, peritonsillar abscess, cervical lymphadenitis, mastoiditis, and, possibly, other invasive infections), to improve clinical symptoms and signs, for the rapid decrease in contagiousness, for the reduction in transmission of GAS to family members, classmates, and other close contacts of the patient to allow for the rapid resumption of usual activities; and for the minimization of potential adverse effects of inappropriate antimicrobial therapy.
Medical Therapy
- Acute pharyngitis should be treated according to the etiologic agent.[1]
- As viral infections are the most common causes of pharyngitis in children, most patients do not require treatment and only need supportive care.[2]
- Bacterial pharyngitis is common among young children and adolescents. Group A streptococcal pharyngitis is the only common form of the disease for which antimicrobial therapy is definitely indicated. Therefore, when a clinician evaluates a patient with an acute sore throat, the most important clinical task is to decide whether or not the patient has “strep throat.”[3]
Corticosteroids
Corticosteroids have been studied and recommended by a guideline[4], but results were heterogeneous in a meta-analysis[5].
The most recent trial in the meta-analysis showed[6]:
- Insignificant benefit in the primary outcome at 24 hours. Risk difference of 4.7% (95% CI, −1.8% to 11.2%)
- Significant benefit at the secondary outcome of 48 hours. Risk difference of 8.7% (95% CI, 1.2% to 16.2%)
Other Treatment Regimen
Supportive Therapies | Systemic Therapy | Antimicrobial Regimens |
---|---|---|
Topical therapy
Oral rinses
Sprays
Lozenges
|
Analgesics
Glucocorticoids
|
Streptococcal pharyngitis[3]
Other bacterial pharyngitis
|
Chronic Carriers of Group A Streptococci
Antimicrobial therapy is not indicated for the majority of chronic carriers. A few conditions where antibiotics are recommended are:
- An outbreak of rheumatic fever, acute poststreptococcal glomerulonephritis or invasive GAS infection
- Closed community outbreak of GAS pharyngitis
- Family history of acute rheumatic fever
- Excessive anxiety about rheumatic fever
References
- ↑ Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. (2012) Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 55 (10):1279-82. DOI:10.1093/cid/cis847 PMID: 23091044
- ↑ Bisno AL (1996) Acute pharyngitis: etiology and diagnosis. Pediatrics 97 (6 Pt 2):949-54. PMID: 8637780
- ↑ 3.0 3.1 3.2 3.3 3.4 Bisno AL (2001) Acute pharyngitis. N Engl J Med 344 (3):205-11. DOI:10.1056/NEJM200101183440308 PMID: 11172144
- ↑ Aertgeerts B, Agoritsas T, Siemieniuk RAC, Burgers J, Bekkering GE, Merglen A; et al. (2017). "Corticosteroids for sore throat: a clinical practice guideline". BMJ. 358: j4090. doi:10.1136/bmj.j4090. PMID 28931507. ACPJC review
- ↑ Sadeghirad B, Siemieniuk RAC, Brignardello-Petersen R, Papola D, Lytvyn L, Vandvik PO; et al. (2017). "Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. doi:10.1136/bmj.j3887. PMC 5605780. PMID 28931508.
- ↑ Hayward GN, Hay AD, Moore MV, Jawad S, Williams N, Voysey M; et al. (2017). "Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial". JAMA. 317 (15): 1535–1543. doi:10.1001/jama.2017.3417. PMC 5470351. PMID 28418482. Review in: Ann Intern Med. 2017 Aug 15;167(4):JC16
- ↑ Patel SK, Ghufoor K, Jayaraj SM, McPartlin DW, Philpott J (1999) Pictorial assessment of the delivery of oropharyngeal rinse versus oropharyngeal spray. J Laryngol Otol 113 (12):1092-4. PMID: 10767923
- ↑ Hess GP, Walson PD (1988) Seizures secondary to oral viscous lidocaine. Ann Emerg Med 17 (7):725-7. PMID: 3382075
- ↑ Gonzalez del Rey J, Wason S, Druckenbrod RW (1994) Lidocaine overdose: another preventable case? Pediatr Emerg Care 10 (6):344-6. PMID: 7899121
- ↑ Turnbull RS (1995) Benzydamine Hydrochloride (Tantum) in the management of oral inflammatory conditions. J Can Dent Assoc 61 (2):127-34. PMID: 7600413
- ↑ Passàli D, Volonté M, Passàli GC, Damiani V, Bellussi L, MISTRAL Italian Study Group (2001) Efficacy and safety of ketoprofen lysine salt mouthwash versus benzydamine hydrochloride mouthwash in acute pharyngeal inflammation: a randomized, single-blind study. Clin Ther 23 (9):1508-18. PMID: 11589263
- ↑ Cingi C, Songu M, Ural A, Erdogmus N, Yildirim M, Cakli H et al. (2011) Effect of chlorhexidine gluconate and benzydamine hydrochloride mouth spray on clinical signs and quality of life of patients with streptococcal tonsillopharyngitis: a multicentre, prospective, randomized, double-blinded, placebo-controlled study. J Laryngol Otol 125 (6):620-5. DOI:10.1017/S0022215111000065 PMID: 21310101
- ↑ Cingi C, Songu M, Ural A, Yildirim M, Erdogmus N, Bal C (2010) Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: a prospective, randomized, double-blind, placebo-controlled, multicenter study. Ear Nose Throat J 89 (11):546-9. PMID: 21086279
- ↑ Watson N, Nimmo WS, Christian J, Charlesworth A, Speight J, Miller K (2000) Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety. Int J Clin Pract 54 (8):490-6. PMID: 11198725
- ↑ Weckmann G, Hauptmann-Voß A, Baumeister SE, Klötzer C, Chenot JF (2017). "Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis". Int J Clin Pract. doi:10.1111/ijcp.13002. PMID 28869700.
- ↑ Thomas M, Del Mar C, Glasziou P (2000) How effective are treatments other than antibiotics for acute sore throat? Br J Gen Pract 50 (459):817-20. PMID: 11127175
- ↑ Gehanno P, Dreiser RL, Ionescu E, Gold M, Liu JM (2003) Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat. Clin Drug Investig 23 (4):263-71. PMID: 17535039
- ↑ Olympia RP, Khine H, Avner JR (2005) Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med 159 (3):278-82. DOI:10.1001/archpedi.159.3.278 PMID: 15753273
- ↑ O'Brien JF, Meade JL, Falk JL (1993) Dexamethasone as adjuvant therapy for severe acute pharyngitis. Ann Emerg Med 22 (2):212-5. PMID: 8427434
- ↑ Bulloch B, Kabani A, Tenenbein M (2003) Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial. Ann Emerg Med 41 (5):601-8. DOI:10.1067/mem.2003.136 PMID: 12712025